Trials / Completed
CompletedNCT01823705
Gastric Electrical Stimulation (GES) for the Treatment of Obesity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Medtronic Corporate Technologies and New Ventures · Industry
- Sex
- All
- Age
- 21 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this feasibility study is to provide safety data on the implantable Exilis gastric electrical stimulation (GES) system, to individually adjust stimulation parameters to levels that are comfortable for implanted subjects during chronic daily treatment, and to collect data on acute gastrointestinal function and food intake responses to GES during in-clinic testing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Exilis Implantable Gastric Electrical Stimulation (GES) |
Timeline
- Start date
- 2013-03-29
- Primary completion
- 2017-01-13
- Completion
- 2017-01-13
- First posted
- 2013-04-04
- Last updated
- 2018-10-02
Locations
4 sites across 2 countries: United States, Netherlands
Source: ClinicalTrials.gov record NCT01823705. Inclusion in this directory is not an endorsement.